Facebook
TwitterAfter over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic. Data about COVID-19 will continue to be updated at CDC’s COVID Data Tracker.
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
It is a weekly snapshot in time that:
Facebook
TwitterThe New York Times is releasing a series of data files with cumulative counts of coronavirus cases in the United States, at the state and county level, over time. We are compiling this time series data from state and local governments and health departments in an attempt to provide a complete record of the ongoing outbreak.
Since late January, The Times has tracked cases of coronavirus in real time as they were identified after testing. Because of the widespread shortage of testing, however, the data is necessarily limited in the picture it presents of the outbreak.
We have used this data to power our maps and reporting tracking the outbreak, and it is now being made available to the public in response to requests from researchers, scientists and government officials who would like access to the data to better understand the outbreak.
The data begins with the first reported coronavirus case in Washington State on Jan. 21, 2020. We will publish regular updates to the data in this repository.
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic. Data about COVID-19 will continue to be updated at CDC’s COVID Data Tracker.
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
It is a weekly snapshot in time that:
Facebook
TwitterAs of March 10, 2023, the death rate from COVID-19 in the state of New York was 397 per 100,000 people. New York is one of the states with the highest number of COVID-19 cases.
Facebook
TwitterNNDSS - TABLE 1FF. Severe acute respiratory syndrome-associated coronavirus disease to Shigellosis - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.
Note: This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html.
Footnotes: U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data. -: No reported cases — The reporting jurisdiction did not submit any cases to CDC. N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction. NN: Not nationally notifiable — This condition was not designated as being nationally notifiable. NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized. Cum: Cumulative year-to-date counts. Max: Maximum — Maximum case count during the previous 52 weeks. * Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Facebook
TwitterNote: Authorizations to collect certain public health data expired at the end of the U.S. public health emergency declaration on May 11, 2023. The following jurisdictions discontinued COVID-19 case notifications to CDC: Iowa (11/8/21), Kansas (5/12/23), Louisiana (10/31/23), New Hampshire (5/23/23), and Oklahoma (5/2/23). Please note that these jurisdictions will not routinely send new case data after the dates indicated. As of 7/13/23, case notifications from Oregon will only include pediatric cases resulting in death.
This table summarizes COVID-19 case and death data submitted to CDC as case reports for the line-level dataset. Case and death counts are stratified according to sex, age, and race and ethnicity at regional and national levels. Data for US territories are included in case and death counts, but not population counts. Weekly cumulative counts with five or fewer cases or deaths are not reported to protect confidentiality of patients. Records with unknown or missing sex, age, or race and ethnicity and of multiple, non-Hispanic race and ethnicity are included in case and death totals. COVID-19 case and death data are provisional and are subject to change. Visualization of COVID-19 case and death rate trends by demographic variables may be viewed on COVID Data Tracker (https://covid.cdc.gov/covid-data-tracker/#demographicsovertime).
Facebook
TwitterAfter May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations. The following dataset provides state-aggregated data for hospital utilization in a timeseries format dating back to January 1, 2020. These are derived from reports with facility-level granularity across three main sources: (1) HHS TeleTracking, (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities and (3) National Healthcare Safety Network (before July 15). The file will be updated regularly and provides the latest values reported by each facility within the last four days for all time. This allows for a more comprehensive picture of the hospital utilization within a state by ensuring a hospital is represented, even if they miss a single day of reporting. No statistical analysis is applied to account for non-response and/or to account for missing data. The below table displays one value for each field (i.e., column). Sometimes, reports for a given facility will be provided to more than one reporting source: HHS TeleTracking, NHSN, and HHS Protect. When this occurs, to ensure that there are not duplicate reports, prioritization is applied to the numbers for each facility. On April 27, 2022 the following pediatric fields were added: all_pediatric_inpatient_bed_occupied all_pediatric_inpatient_bed_occupied_coverage all_pediatric_inpatient_beds all_pediatric_inpatient_beds_coverage previous_day_admission_pediatric_covid_confirmed_0_4 previous_day_admission_pediatric_covid_confirmed_0_4_coverage previous_day_admission_pediatric_covid_confirmed_12_17 previous_day_admission_pediatric_covid_confirmed_12_17_coverage previous_day_admission_pediatric_covid_confirmed_5_11 previous_day_admission_pediatric_covid_confirmed_5_11_coverage previous_day_admission_pediatric_covid_confirmed_unknown previous_day_admission_pediatric_covid_confirmed_unknown_coverage staffed_icu_pediatric_patients_confirmed_covid staffed_icu_pediatric_patients_confirmed_covid_coverage staffed_pediatric_icu_bed_occupancy staffed_pediatric_icu_bed_occupancy_coverage total_staffed_pediatric_icu_beds total_staffed_pediatric_icu_beds_coverage On January 19, 2022, the following fields have been added to this dataset: inpatient_beds_used_covid inpatient_beds_used_covid_coverage On September 17, 2021, this data set has had the following fields added: icu_patients_confirmed_influenza, icu_patients_confirmed_influenza_coverage, previous_day_admission_influenza_confirmed, previous_day_admission_influenza_confirmed_coverage, previous_day_deaths_covid_and_influenza, previous_day_deaths_covid_and_influenza_coverage, previous_day_deaths_influenza, previous_day_deaths_influenza_coverage, total_patients_hospitalized_confirmed_influenza, total_patients_hospitalized_confirmed_influenza_and_covid, total_patients_hospitalized_confirmed_influenza_and_covid_coverage, total_patients_hospitalized_confirmed_influenza_coverage On September 13, 2021, this data set has had the following fields added: on_hand_supply_therapeutic_a_casirivimab_imdevimab_courses, on_hand_supply_therapeutic_b_bamlanivimab_courses, on_hand_supply_therapeutic_c_bamlanivimab_etesevimab_courses, previous_week_therapeutic_a_casirivimab_imdevimab_courses_used, previous_week_therapeutic_b_bamlanivimab_courses_used, previous_week_therapeutic_c_bamlanivima
Facebook
TwitterMaps, charts, and data provided by the CDC for tracking COVID-19
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States SB: VA: COVID-19 Impact: Little or Number Effect data was reported at 28.400 % in 11 Apr 2022. This records an increase from the previous number of 25.500 % for 04 Apr 2022. United States SB: VA: COVID-19 Impact: Little or Number Effect data is updated weekly, averaging 26.800 % from Nov 2021 (Median) to 11 Apr 2022, with 18 observations. The data reached an all-time high of 30.600 % in 22 Nov 2021 and a record low of 21.400 % in 07 Mar 2022. United States SB: VA: COVID-19 Impact: Little or Number Effect data remains active status in CEIC and is reported by U.S. Census Bureau. The data is categorized under Global Database’s United States – Table US.S051: Small Business Pulse Survey: by State: South Region: Weekly, Beg Monday (Discontinued).
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
After October 13, 2022, this dataset will no longer be updated as the related CDC COVID Data Tracker site was retired on October 13, 2022.
This dataset contains historical trends in vaccinations and cases by age group, at the US national level. Data is stratified by at least one dose and fully vaccinated. Data also represents all vaccine partners including jurisdictional partner clinics, retail pharmacies, long-term care facilities, dialysis centers, Federal Emergency Management Agency and Health Resources and Services Administration partner sites, and federal entity facilities.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States SB: VA: COVID-19 Impact: Moderate Negative Effect data was reported at 39.800 % in 11 Apr 2022. This records a decrease from the previous number of 41.900 % for 04 Apr 2022. United States SB: VA: COVID-19 Impact: Moderate Negative Effect data is updated weekly, averaging 41.700 % from Nov 2021 (Median) to 11 Apr 2022, with 18 observations. The data reached an all-time high of 47.600 % in 06 Dec 2021 and a record low of 39.000 % in 22 Nov 2021. United States SB: VA: COVID-19 Impact: Moderate Negative Effect data remains active status in CEIC and is reported by U.S. Census Bureau. The data is categorized under Global Database’s United States – Table US.S051: Small Business Pulse Survey: by State: South Region: Weekly, Beg Monday (Discontinued).
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
After over two years of public reporting, the Community Profile Report - National Level Dataset will no longer be produced and distributed after the end of the public health emergency declaration. The final release will be on May 15, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Effective June 22, 2021, the Community Profile Report will only be updated twice a week, on Tuesdays and Fridays.
The Community Profile Report (CPR) – County-Level is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, under the White House COVID-19 Team. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the Assistant Secretary for Preparedness and Response, and the Indian Health Service).
This data table provides national-level information.
Facebook
TwitterAn analysis published in May 2022 found that of the total 641,305 COVID-19 deaths reported in the United States between January 1, 2021 and April 30, 2022, around 318,981 could have been prevented if 100 percent of the population was vaccinated. During this period the state of West Virginia reported about 5,483 deaths related to COVID-19. It is estimated that if 100 percent of the population of West Virginia had been vaccinated then 3,350 of these deaths, or 61 percent, could have been prevented. As of May 2022, around 66 percent of the U.S. population had been fully vaccinated against COVID-19. This table shows the number of COVID-19 deaths in the United States between January 2021 and April 2022 that could have been prevented if 100 percent of the population had been vaccinated, by state.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States Excess Deaths excl COVID: Predicted: Above Expected: West Virginia data was reported at 0.000 Number in 09 Oct 2021. This stayed constant from the previous number of 0.000 Number for 02 Oct 2021. United States Excess Deaths excl COVID: Predicted: Above Expected: West Virginia data is updated weekly, averaging 0.000 Number from Jan 2017 (Median) to 09 Oct 2021, with 248 observations. The data reached an all-time high of 103.000 Number in 06 Jan 2018 and a record low of 0.000 Number in 09 Oct 2021. United States Excess Deaths excl COVID: Predicted: Above Expected: West Virginia data remains active status in CEIC and is reported by Centers for Disease Control and Prevention. The data is categorized under Global Database’s United States – Table US.G012: Number of Excess Deaths: by States: All Causes excluding COVID-19: Predicted (Discontinued).
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: N/A data was reported at 13.600 % in 11 Apr 2022. This records an increase from the previous number of 11.700 % for 04 Apr 2022. United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: N/A data is updated weekly, averaging 13.900 % from Nov 2021 (Median) to 11 Apr 2022, with 18 observations. The data reached an all-time high of 17.500 % in 03 Jan 2022 and a record low of 11.700 % in 04 Apr 2022. United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: N/A data remains active status in CEIC and is reported by U.S. Census Bureau. The data is categorized under Global Database’s United States – Table US.S051: Small Business Pulse Survey: by State: South Region: Weekly, Beg Monday (Discontinued).
Facebook
TwitterEffective June 28, 2023, this dataset will no longer be updated. Similar data are accessible from CDC WONDER (https://wonder.cdc.gov/mcd-icd10-provisional.html) Provisional count of deaths involving COVID-19 by county of occurrence, in the United States, 2020-2023.
Facebook
Twitterhttps://www.usa.gov/government-workshttps://www.usa.gov/government-works
Deaths counts for influenza, pneumonia, and COVID-19 reported to NCHS by week ending date, by state and HHS region, and age group.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: Yes data was reported at 8.300 % in 11 Apr 2022. This records a decrease from the previous number of 11.000 % for 04 Apr 2022. United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: Yes data is updated weekly, averaging 12.650 % from Nov 2021 (Median) to 11 Apr 2022, with 18 observations. The data reached an all-time high of 15.600 % in 27 Dec 2021 and a record low of 6.800 % in 28 Mar 2022. United States SB: VA: COVID Test/Vaccine: Proof of COVID Vaccination: Yes data remains active status in CEIC and is reported by U.S. Census Bureau. The data is categorized under Global Database’s United States – Table US.S051: Small Business Pulse Survey: by State: South Region: Weekly, Beg Monday (Discontinued).
Facebook
TwitterThis dataset was collected from data received via this APi.
“[Recovered cases are a] more important metric to track than Confirmed cases.”— Researchers for the University of Virginia’s COVID-19 dashboard
If the number of total cases were accurately known for every country then the number of cases per million people would be a good indicator as to how well various countries are handling the pandemic.
| № | column name | Dtype | description |
|---|---|---|---|
| 0 | index | int64 | index |
| 1 | continent | object | Any of the world's main continuous expanses of land (Europe, Asia, Africa, North and South America, Oceania) |
| 2 | country | object | A country is a distinct territorial body |
| 3 | population | float64 | The total number of people in the country |
| 4 | day | object | YYYY-mm-dd |
| 5 | time | object | YYYY-mm-dd T HH :MM:SS+UTC |
| 6 | cases_new | object | The difference in relation to the previous record of all cases |
| 7 | cases_active | float64 | Total number of current patients |
| 8 | cases_critical | float64 | Total number of current seriously ill |
| 9 | cases_recovered | float64 | Total number of recovered cases |
| 10 | cases_1M_pop | object | The number of cases per million people |
| 11 | cases_total | int64 | Records of all cases |
| 12 | deaths_new | object | The difference in relation to the previous record of all cases |
| 13 | deaths_1M_pop | object | The number of cases per million people |
| 14 | deaths_total | float64 | Records of all cases |
| 15 | tests_1M_pop | object | The number of cases per million people |
| 16 | tests_total | float64 | Records of all cases |
Datasets contend data about covid_19 from 232 countries - Afghanistan - Albania - Algeria - Andorra - Angola - Anguilla - Antigua-and-Barbuda - Argentina - Armenia - Aruba - Australia - Austria - Azerbaijan - Bahamas - Bahrain - Bangladesh - Barbados - Belarus - Belgium - Belize - Benin - Bermuda - Bhutan - Bolivia - Bosnia-and-Herzegovina - Botswana - Brazil - British-Virgin-Islands - Brunei - Bulgaria - Burkina-Faso - Burundi - Cabo-Verde - Cambodia - Cameroon - Canada - CAR - Caribbean-Netherlands - Cayman-Islands - Chad - Channel-Islands - Chile - China - Colombia - Comoros - Congo - Cook-Islands - Costa-Rica - Croatia - Cuba - Curaçao - Cyprus - Czechia - Denmark - Diamond-Princess - Diamond-Princess- - Djibouti - Dominica - Dominican-Republic - DRC - Ecuador - Egypt - El-Salvador - Equatorial-Guinea - Eritrea - Estonia - Eswatini - Ethiopia - Faeroe-Islands - Falkland-Islands - Fiji - Finland - France - French-Guiana - French-Polynesia - Gabon - Gambia - Georgia - Germany - Ghana - Gibraltar - Greece - Greenland - Grenada - Guadeloupe - Guam - Guatemala - Guinea - Guinea-Bissau - Guyana - Haiti - Honduras - Hong-Kong - Hungary - Iceland - India - Indonesia - Iran - Iraq - Ireland - Isle-of-Man - Israel - Italy - Ivory-Coast - Jamaica - Japan - Jordan - Kazakhstan - Kenya - Kiribati - Kuwait - Kyrgyzstan - Laos - Latvia - Lebanon - Lesotho - Liberia - Libya - Liechtenstein - Lithuania - Luxembourg - Macao - Madagascar - Malawi - Malaysia - Maldives - Mali - Malta - Marshall-Islands - Martinique - Mauritania - Mauritius - Mayotte - Mexico - Micronesia - Moldova - Monaco - Mongolia - Montenegro - Montserrat - Morocco - Mozambique - MS-Zaandam - MS-Zaandam- - Myanmar - Namibia - Nepal - Netherlands - New-Caledonia - New-Zealand - Nicaragua - Niger - Nigeria - Niue - North-Macedonia - Norway - Oman - Pakistan - Palau - Palestine - Panama - Papua-New-Guinea - Paraguay - Peru - Philippines - Poland - Portugal - Puerto-Rico - Qatar - Réunion - Romania - Russia - Rwanda - S-Korea - Saint-Helena - Saint-Kitts-and-Nevis - Saint-Lucia - Saint-Martin - Saint-Pierre-Miquelon - Samoa - San-Marino - Sao-Tome-and-Principe - Saudi-Arabia - Senegal - Serbia - Seychelles - Sierra-Leone - Singapore - Sint-Maarten - Slovakia - Slovenia - Solomon-Islands - Somalia - South-Africa - South-Sudan - Spain - Sri-Lanka - St-Barth - St-Vincent-Grenadines - Sudan - Suriname - Sweden - Switzerland - Syria - Taiwan - Tajikistan - Tanzania - Thailand - Timor-Leste - Togo - Tonga - Trinidad-and-Tobago - Tunisia - Turkey - Turks-and-Caicos - UAE - Uganda - UK - Ukraine - Uruguay - US-Virgin-Islands - USA - Uzbekistan - Vanuatu - Vatican-City - Venezuela - Vietnam - Wallis-and-Futuna - Western-Sahara - Yemen - Zambia - Zimbabw-
Facebook
TwitterMore than 450 public health and clinical laboratories located throughout the United States participate in surveillance for severe acute respiratory virus coronavirus type 2 (SARS-CoV-2), the virus that causes COVID-19, through CDC's National Respiratory and Enteric Virus Surveillance System (NREVSS). The dataset contains a weekly summary of aggregate counts of the total SARS-CoV-2 tests and SARS-CoV-2 detections reported to NREVSS since March 14, 2020. These data are reported weekly on a voluntary basis. Clinical laboratories do not report demographic data through NREVSS. Testing practices may vary regionally, and the number of participating laboratories may change from year to year. Results can be changed for up to 2 years after the initial reporting week. However, discrepancies may be noted and updated at the discretion of the data stewards and key stakeholders.
While NREVSS strives to present the most precise estimates of respiratory viral trends with reporting burden minimized for participating laboratories, there are several inherent limitations to this surveillance system.
NREVSS does not collect patient-specific data or demographic information. Multiple samples may be collected from a single patient, so NREVSS results do not necessarily reflect the number of patients tested, nor do they directly reflect hospitalizations or deaths related to COVID-19.
Participating laboratories vary in size, testing capabilities, and areas served. Some institutions may receive and test samples from sites across a given state or even from multiple states. Without direct knowledge of the population base, NREVSS cannot be used to determine the prevalence or incidence of infection.
For more information on NREVSS and COVID-19 surveillance please visit: https://www.cdc.gov/surveillance/nrevss. These data appear starting May 25, 2023 on the CDC COVID Data Tracker at the following URLs: https://covid.cdc.gov/covid-data-tracker/#trends ; https://covid.cdc.gov/covid-data-tracker/#cases.
NREVSS data are reported at the national and HHS regional levels. The ten (10) U.S. Department of HHS regions are defined here: https://www.hhs.gov/about/agencies/iea/regional-offices/index.html.
The data represent SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) results, which include reverse transcriptase-polymerase chain reaction (RT-PCR) tests from a voluntary, sentinel network of participating laboratories in the United States, including clinical, public health and commercial laboratories (https://www.cdc.gov/surveillance/nrevss/labs/index.html).
These data exclude antigen, antibody, and at-home test results.
All data are provisional and subject to change. Reporting is less complete for the past 1 week, and more complete (>90%) for the period 2 weeks earlier.
There are data from all states across the 10 HHS regions. Because the data are from a sentinel network of laboratories, however, results may vary geographically. The data do not include all test results within a jurisdiction and therefore do not reflect all SARS-CoV-2 NAATs administered in the United States.
Percent positivity is one of the surveillance metrics used to monitor COVID-19 transmission over time and by area. Percent positivity is calculated by dividing the number of positive NAATs by the total number of NAATs administered, then multiplying by 100 [(# of positive NAAT tests / total NAAT tests) x 100].
The data represent laboratory tests performed, not individual (deduplicated) results in people. In the table and upon hovering on the map, the total test counts in the data reflect the latest data reported from NREVSS laboratories and may not match the data presented by various jurisdictions.
On May 11, 2023, CDC discontinued utilizing the COVID electronic laboratory reporting (CELR) platform as the primary laboratory source of COVID-19 results. These data are archived at health.data.gov.
For more information about NREVSS, please see: https://www.cdc.gov/surveillance/nrevss/index.html.
Facebook
TwitterAfter over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic. Data about COVID-19 will continue to be updated at CDC’s COVID Data Tracker.
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
It is a weekly snapshot in time that: